Incidence and progression of diabetic retinopathy in Hispanics and non- Hispanic whites with type 2 diabetes: San Luis Valley diabetes study, Colorado

Diabetes Care

Volumn 21, Issue 1, 1998, Pages 53-61

  Tudor, Stephanie M ^a   Hamman, Richard F ^a   Baron, Anna ^a   Johnson, David W ^a   Shetterly, Susan M ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; ETHNIC GROUP; FEMALE; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RACE DIFFERENCE; RISK FACTOR; UNITED STATES;

EID: 2642710059     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.1.53     Document Type: Article

References (49)

1. Klein R, Klein BEK: Vision disorders in diabetes. In Diabetes in America. 2nd ed. National Diabetes Data Group, Ed. Washington, DC, U.S. Govt. Printing Office, 1995, p. 293-338
2. Kahn HA, Hiller R: Blindness caused by diabetic retinopathy. Am J Ophthalmol 78:58-67, 1974
3. Klein R, Klein BE, Moss SE: Visual impairment in diabetes. Ophthalmology 91:1-9, 1984
4. Hamman RF, Mayer ES, Moo-Young G, Hildebrandt W, Marshall JA, Baxter J: Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM: the San Luis Valley Diabetes Study. Diabetes 38:1231-1237, 1989
5. Stern MP, Mitchell BD: Diabetes in Hispanic Americans. In Diabetes in America. 2nd ed. National Diabetes Data Group, Ed. Washington, DC, U.S. Govt. Printing Office, 1995, p. 631-659
6. Haffner SM, Fong D, Stern MP, Pugh JA, Hazuda HP, Patterson JK, van Heuven WA, Klein R: Diabetic retinopathy in Mexican Americans and non-Hispanic whites. Diabetes 37:878-884, 1988
7. Lee ET, Lee VS, Lu M, Russell D: Development of proliferative retinopathy in NIDDM: a follow-up study of American Indians in Oklahoma. Diabetes 41:359-367, 1992
8. Nelson RG, Wolfe JA, Horton MB, Pettitt DJ, Bennett PH, Knowler WC: Proliferative retinopathy in NIDDM. incidence and risk factors in Pima Indians. Diabetes 38:435-440, 1989
9. Fujimoto WY, Leonetti DL, Kinyoun JL, Shuman WP, Stolov WC, Wahl PW: Prevalence of complications among second-generation Japanese-American men with diabetes, impaired glucose tolerance, or normal glucose tolerance. Diabetes 36: 730-739, 1987
10. Sasaki A, Horiuchi N, Hasewgawa K, Uehara M: Development of diabetic retinopathy and its associated risk factors in type 2 diabetic patients in Osaka district, Japan: a long-term prospective study. Diabetes Res Clin Pract 10:257-263, 1990
11. Collins VR, Dowse GK, Plehwe WE, Imo TT, Toelupe PM, Taylor HR, Zimmet PZ: High prevalence of diabetic retinopathy and nephropathy in Polynesians of Western Samoa. Diabetes Care 18:1140-1149, 1995
12. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol 107:244-249, 1989
13. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102:527-532, 1984
14. Dorf A, Ballintine EJ, Bennett PH, Miller M: Retinopathy in Pima Indians: relationships to glucose level, duration of diabetes, age at diagnosis of diabetes, and age at examination in a population with a high prevalence of diabetes mellitus. Diabetes 25:554-560, 1976
15. West KM, Erdreich LJ, Stober JA: A detailed study of risk factors for retinopathy and nephropathy in diabetes. Diabetes 29:501-508, 1980
16. Haffner SM, Hazuda HP, Stern MP, Patterson JK, VanHeuven WAJ, Fong D: Effect of socioeconomic status on hyperglycemia and retinopathy levels in Mexican Americans with NIDDM. Diabetes Care 12:128-134, 1989
17. Knowler WC, Bennett PH, Ballintine EJ: Increased incidence of retinopathy in diabetics with elevated blood pressure: a six-year follow-up study in Pima Indians. N Engl J Med 302:645-650, 1980
18. Knuiman MW, Welborn TA, McCann VJ, Stanton KG, Constable IJ: Prevalence of diabetic complications in relation to risk factors. Diabetes 35:1332-1339, 1986
19. Nathan DM, Singer DE, Godine JE, Harrington CH, Perlmuter LC: Retinopathy in older type II diabetics: association with glucose control. Diabetes 35:797-801, 1986
20. Ic) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44:968-983, 1995
21. Hamman RF, Marshall JA, Baxter J, Kahn LR, Mayer EJ, Orleans M, Murphy JR, Lezotte DC: Methods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population: the San Luis Valley Diabetes Study. Am J Epidemiol 129:295-311, 1989
22. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
23. SAS Procedures Guide for Personal Computers, Ver 6. Cary, NC, SAS Institute, 1985
24. Early Treatment Diabetic Retinopathy Study Research Group: Grading diabetic retinopathy from stereoscopic color fundus photographs: an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98:786-806, 1991
25. Klein R, Klein BEK, Magli YL, Brothers RJ, Meuer SM, Moss SE, Davis MD: An alternative method of grading diabetic retinopathy. Ophthalmology 93:1183-1187, 1986
26. Diabetic Retinopathy Study Research Group: Report 7: a modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 21:210-226, 1981
27. U.S. Department of Commerce, Bureau of the Census: 1980 Census of Population, Vol. 1, General Social and Economic Characteristics of the Population. Washington, DC, U.S. Government Printing Office, 1983 (Colorado PC80-1-C7)
28. Gay EC, Cruickshanks KJ, Chase HP, Klingensmith GJ, Hamman RF: Accuracy of a filter paper method for measuring glycosylated hemoglobin. Diabetes Care 15:108-110, 1992
29. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, MD, National Institutes of Health, National Heart, Lung, and Blood Institute, 1993
30. Bennett PH: Recommendations on the standardization of methods and reporting of tests for diabetes and its microvascular complications in epidemiologic studies. Diabetes Care 2:98-104, 1979
31. Stavropoulos WS, Crouch RD: A new caloric procedure for the determination of serum triacylglycerol (Abstract). Clin Chem 20:857, 1974.
32. Richmond W: Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 19:1350-1356, 1973
33. Warnick GR, Benderson J, Alber JJ: Dextran sulfate-Mg2+ precipitation procedures for quantitation of high-density-lipoprotein cholesterol. Clin Chem 23:1379-1388, 1982
34. Gahlinger PM, Abramson JH: PEPI: computer programs for epidemiologic analysis. Stone Mountain, GA, USD, 1996
35. Rothman KJ: Modern Epidemiology. Boston, MA, Little, Brown, 1986
36. Sakamoto Y, Ishiguro M, Kitagawa G: Akaike information criterion. In Akaike Information Criterion Statistics. Tokyo, KTK Scientific, 1986, p. 56-85
37. Sands ML, Shetterly SM, Franklin GM, Hamman RF: Incidence of distal symmetric (sensory) neuropathy in NIDDM: the San Luis Valley Diabetes Study. Diabetes Care 20:322-329, 1997
38. Klein R, Klein BEK, Moss SE, Cruickshanks KJ: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 112:1217-1228, 1994
39. Klein R, Klein BEK, Neider MW, Hubbard LD, Meuer SM, Brothers RJ: Diabetic retinopathy as detected using ophthalmoscopy, a nonmydriatic camera, and a standard fundus camera. Ophthalmology 92:485-491, 1985
40. Haffner SM, Mitchell BD, Moss SE, Stern MP, Hazuda HP, Patterson J, van Heuven WA, Klein R: Is there an ethnic difference in the effect of risk factors for diabetic retinopathy? Ann Epidemiol 3:2-8, 1993
41. Pugh JA, Tuley MR, Hazuda HP, Stern MP: The influence of outpatient insurance coverage on the microvascular complications of non-insulin-dependent diabetes in Mexican Americans. J Diabetes Complications 6:236-241, 1992
42. Barnett AH, Britton JR, Leatherdale BA: Study of possible risk factors for severe retinopathy in non-insulin dependent diabetes. Br Med J (Clin Res Ed) 287:529, 1983
43. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? Arch Intern Med 149:2427-2432, 1989
44. Baxter J, Hamman RF, Lopez TK, Marshall JA, Hoag S, Swenson CL: Excess incidence of known non-insulin-dependent diabetes mellitus (NIDDM) in Hispanics compared with non-Hispanic whites in the San Luis Valley, Colorado. Ethnic Dis 3:11-21, 1993
45. Nielsen NV: Diabetic retinopathy. I. The course of retinopathy in insulin-treated diabetics: a one year epidemiological cohort study of diabetes mellitus: the Island of Falster, Denmark. Acta Ophthalmol 62: 256-265, 1984
46. Nielsen NV: Diabetic retinopathy II. The course of retinopathy in diabetics treated with oral hypoglycaemic agents and diet regime alone: a one year epidemiological cohort study of diabetes mellitus: the Island of Falster, Denmark. Acta Ophthalmol 62: 266-273, 1984
47. Chen MS, Kao CS, Fu CC, Chen CJ, Tai TY: Incidence and progression of diabetic retinopathy among non-insulin-dependent diabetic subjects: a 4-year follow-up. Int J Epidemiol 24:787-795, 1995
48. Dwyer MS, Melton LJ, Ballard DJ, Palumbo PJ, Trautmann JC, Chu C-P: Incidence of diabetic retinopathy and blindness: a population-based study in Rochester, Minnesota. Diabetes Care 8:316-322, 1985
49. Lee ET, Lee VS, Kingsley RM, Lu M, Russell D, Asal NR, Wilkinson CP, Bradford RH Jr: Diabetic retinopathy in Oklahoma Indians with NIDDM. Diabetes Care 15:1620-1627, 1992